The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

(RTTNews) - IceCure Medical Ltd. (ICCM), Friday announced that the U.S. Food and Drug Administration's Advisory panel has voted in favor of the company's ProSense technology intended for early-stage ...

A “huge breakthrough ” in new drug therapy for aggressive advanced breast cancer could potentially double the amount of time ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

A three-drug therapy targeting breast cancer could double the amount of time patients live without the disease progressing, a trial has found. Researchers praised the “huge breakthrough” as ...

Collaborative research at the University of Ottawa sheds new light on the mysteries of mitochondrial dynamics and its likely ...

The test identifies patients for targeted therapies in breast, colorectal ... may benefit from treatment with targeted therapies. MI Cancer Seek™ has received approval from the Food and Drug ...

Caris said MI Cancer Seek will be used as a companion diagnostic to identify cancer patients who may benefit from treatment ...

Companies claim that some screenings can identify dozens of cancers from a simple blood test. Here's what they can and can't ...

FDA rule requires mammogram reports to include breast density info, crucial for detecting cancer in dense breasts.

Mitochondria have long been known as the tiny organelles that act as the battery packs inside our cells while also serving as internal sensors and communicators.

announced the U.S. Food and Drug Administration's ("FDA") Medical Device Advisory Committee Panel's (the "Advisory Panel") favorable recommendation with 9 panelists voting in favor and 5 voting ...